期刊
SEMINARS IN CANCER BIOLOGY
卷 20, 期 6, 页码 391-399出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2010.08.004
关键词
Chronic lymphocytic leukaemia; B-cell receptor; Signalling; Anergy
类别
资金
- Kay Kendall Leukaemia Fund, Tenovus UK, Tenovus Solentside
- Experimental Cancer Medicine Centre (ECMC) network
The key molecule for normal B cells is the surface Ig (sIg) of the B-cell receptor, which influences cell behaviour, even after neoplastic transformation. During B-cell maturation, sIg accumulates somatic mutations in the Ig variable region (V) genes and tumours retain these patterns, thereby revealing the point of differentiation of the B cell of origin. The importance of origin is strikingly illustrated in CLL where the two major subsets with distinctive clinical behaviour express either unmutated (U) or mutated (M) V genes. Biased selection of VDJ genes also occurs in CLL, allowing further identification of the normal B-cell counterparts, with U-CLL apparently derived from circulating naive B cells. Surface IgM of CLL is functional, with evidence for ongoing interaction with antigen in vivo. Signalling connects to cell survival, proliferation and migration, key determinants of tumour cell behaviour. Probing of B-cell receptor-mediated signalling pathways, either constitutively activated or open for activation, reveals dynamic, possibly repetitive, stimulatory events, likely to occur in tissue sites. Subtle differences in signal responsiveness between U-CLL or M-CLL subsets, together with microenvironmental factors, may explain clinical outcome. Knowledge of the critical signalling pathways should reveal the steps vulnerable to inhibition and allow development of a new range of therapeutic drugs, targeted particularly against the more aggressive subset, U-CLL (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据